1. Home
  2. CNNE vs SLDB Comparison

CNNE vs SLDB Comparison

Compare CNNE & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNNE

Cannae Holdings Inc.

HOLD

Current Price

$13.69

Market Cap

609.0M

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$8.29

Market Cap

674.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNNE
SLDB
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
609.0M
674.4M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
CNNE
SLDB
Price
$13.69
$8.29
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$20.25
$16.36
AVG Volume (30 Days)
369.3K
1.2M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
4.47%
N/A
EPS Growth
N/A
34.97
EPS
N/A
N/A
Revenue
$499,700,000.00
$8,094,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.37
N/A
52 Week Low
$10.46
$3.79
52 Week High
$21.96
$8.87

Technical Indicators

Market Signals
Indicator
CNNE
SLDB
Relative Strength Index (RSI) 43.52 63.34
Support Level $12.59 $6.38
Resistance Level $15.03 $8.87
Average True Range (ATR) 0.52 0.51
MACD -0.13 0.14
Stochastic Oscillator 13.33 96.98

Price Performance

Historical Comparison
CNNE
SLDB

About CNNE Cannae Holdings Inc.

Cannae Holdings Inc is an investment holding company that acquires and actively manages equity interests in operating businesses across various industries. The Company focuses on long-term ownership and seeks to create value by supporting the growth and operations of its portfolio companies through management expertise and strategic oversight. The Company operates through four reportable segments: Restaurant Group, which includes the operations of O'Charleys and 99 Restaurants; Alight, which represents its ownership interest in a technology-enabled human capital and employee benefits solutions provider; Black Knight Football Club (BKFC), which holds interests in professional football clubs; and JANA, which represents its investment in an investment management firm.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: